1,3-dimethyl 2-(prop-2-en-1-yl)propanedioate, 98.0%, 100g

5-Methylquinoline, 95.0%, 1g

N-(3-Chloro-4-fluorophenyl)-6-nitro-7-(phenylsulfonyl)quinazolin-4-amine, 98+%, 1g

1-(4-Bromobutyl)-3-(trifluoromethyl)benzene, 97%, 250mg

3-methylbicyclo[1.1.1]pentane-1-carboxylic acid, 95.0%, 100mg

Ethyl Butyrate>98.0%(GC)500mL

TERT-BUTYL 3-(HYDROXYIMINO)AZETIDINE-1-CARBOXYLATE, 95.0%, 100mg

2-(Bromomethyl)-5-chloro-1,3-difluorobenzene, 95.0%, 1g

1-(1-piperidinylsulfonyl)-1,4-diazepane, 95.0%, 5g

3,5-Dimethylphenol, 97.0%, 1g

1-((2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98%, 5mg

Objectif IOS Fluarex 40x/0,65 à contraste de phase à longue distance de travail, corrigé à l'infini, corrigé pour une épaisseur de boîte de Pétri de 1 mm

ETHYL 2-OXASPIRO[3.3]HEPTANE-6-CARBOXYLATE, 95.0%, 500mg